PROCEPT BioRobotics Revenue and Competitors

License our Company Data API

#1415

Growjo Ranking

Estimated Revenue & Valuation

PROCEPT BioRobotics's estimated annual revenue is currently $235.8M per year.(i)
PROCEPT BioRobotics received $118.0M in venture funding in February 2018.
PROCEPT BioRobotics's estimated revenue per employee is $351,400
PROCEPT BioRobotics's total funding is $349M.

Employee Data

PROCEPT BioRobotics has 671 Employees.(i)
PROCEPT BioRobotics grew their employee count by 39% last year.

PROCEPT BioRobotics's People

Name	Title	Email/Phone
1 Tom Yorkey	SVP, R&D	Reveal Email/Phone
2 Thomas Arnold	VP Global Marketing	Reveal Email/Phone
3 Bijesh Chandran	SVP, Global RAQA	Reveal Email/Phone
4 Lisa Gildea	VP Sales, US	Reveal Email/Phone
5 Matt Bacso	VP, Investor Relations and Business Operations	Reveal Email/Phone
6 Michael McNeal	VP Global Talent	Reveal Email/Phone
7 Barry Templin	SVP, Medical Affairs and Market Access	Reveal Email/Phone
8 Mohan Sancheti	VP Operations	Reveal Email/Phone
9 Elise Tordella	VP Global Marketing	Reveal Email/Phone
10 Todd Radgowski	VP, PMO and Systems Engineering	Reveal Email/Phone

PROCEPT BioRobotics Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Aperio Technolo...	$20.3M	81	7%	N/A	N/A
#2 Monobind	$8.5M	34	6%	N/A	N/A
#3 Lief Therapeuti...	$4.5M	18	-10%	N/A	N/A
#4 Candelis	$8M	32	-6%	N/A	N/A
#5 Sequent Medical	$5.3M	21	0%	N/A	N/A
#6 Game Ready	$54.2M	216	9%	N/A	N/A
#7 Valencia Techno...	$12M	48	N/A	N/A	N/A
#8 TurnCareâ„¢	$10M	40	5%	N/A	N/A
#9 Caldera Medical	$30.1M	120	22%	N/A	N/A
#10 Skye Biologics	$14.1M	56	2%	N/A	N/A

Add Company

Show More Medical Equip Companies

What Is PROCEPT BioRobotics?

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), the company's first product, the AQUABEAM System delivering Aquablation therapy, is the world's first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

$349M

Total Funding

671

Number of Employees

$235.8M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PROCEPT BioRobotics News

2022-04-06 - PROCEPT BioRobotics Corp. Announces Investor Event at ...

PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans. PROCEPT BioRobotics (GLOBE NEWSWIRE)...

2022-04-06 - PROCEPT BioRobotics Corp. to Report First Quarter 2022 ...

PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare...

2022-04-06 - PROCEPT BioRobotics Corp. Announces Investor Event at ...

REDWOOD CITY, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused...

2021-11-04 - PROCEPT BioRobotics Corp. Reports Third Quarter 2021 Financial Results and Provides 2021 Revenue Guidance

REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the quarter ended September 30, 2021. Re ...